Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation - Top-Institutions - MDSpire

Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation

  • By

  • Nada A. Almarghalani

  • Magdah A. Ganash

  • Mona G. Alharbi

  • Tareq Abualfaraj

  • Almohanad A. Alkayyal

  • Ahmad Bakur Mahmoud

  • July 13, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    National Cancer Institute (NCI), Center for Cancer Research (CCR)
    National Cancer Institute (NCI), Center for Cancer Research (CCR)

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #4

    Broad Institute
    Broad Institute

    Cambridge, Massachusetts

    Key Differentiators

    • Oncology

  • #5

    Dan L. Duncan Comprehensive Cancer Center
    Dan L. Duncan Comprehensive Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

Original Source(s)

Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation

  • by Nada A. Almarghalani, Magdah A. Ganash, Mona G. Alharbi, Tareq Abualfaraj, Almohanad A. Alkayyal, Ahmad Bakur Mahmoud

  • July 13, 2026

Related Content

Case Report: Supraorbital keyhole resection of IDH-mutant grade 3 astrocytoma of the medial orbitofrontal region

Intracranial extramedullary relapse of acute myeloid leukemia presenting as myeloid sarcoma mimicking meningioma: a case report and literature review

Spatial transcriptomics reveals molecular differences associated with malignant transformation in oral epithelial dysplasia